BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32521839)

  • 1. mdm2 oncogene in laryngeal squamous cell carcinoma.
    Mastronikolis N; Ragos V; Fotiades P; Papanikolaou V; Kyrodimos E; Chrysovergis A; Mastronikolis S; Tsiambas E
    J BUON; 2020; 25(2):594-596. PubMed ID: 32521839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53/MDM2 Co-Expression in Laryngeal Squamous Cell Carcinoma Based on Digital Image Analysis.
    Chrysovergis A; Papanikolaou V; Tsiambas E; Stavraka C; Ragos V; Peschos D; Psyrri A; Mastronikolis N; Kyrodimos E
    Anticancer Res; 2019 Aug; 39(8):4137-4142. PubMed ID: 31366498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Jun/c-Fos complex in laryngeal squamous cell carcinoma.
    Tsiambas E; Mastronikolis N; P Fotiades P; Kyrodimos E; Chrysovergis A; Papanikolaou V; Mastronikolis S; Peschos D; Roukas D; Ragos V
    J BUON; 2020; 25(2):618-620. PubMed ID: 32521843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53/MDM2 Complex-Based Targeted Strategies in Colon Adenocarcinoma.
    Niotis A; Tsiambas E; Dimitroulis D; Sarlanis H; Falidas E; Kavantzas N; Constantinides CA
    Acta Med Acad; 2023 Apr; 52(1):24-29. PubMed ID: 37326394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Effect of HPV and Several Gene SNPs in Laryngeal Cancer.
    Stumbrytė-Kaminskienė A; Gudlevičienė Ž; Dabkevičienė D; Mackevičienė I
    Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32079256
    [No Abstract]   [Full Text] [Related]  

  • 6. [Expression and clinical significance of MDM2 and P16 in laryngeal squamous cell carcinoma].
    Li D; Zhang Q; Zhang X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(18):802-5. PubMed ID: 23259295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation-mediated downregulation of lncRNA SSTR5-AS1 promotes progression and metastasis of laryngeal squamous cell carcinoma.
    Wang B; Zhao L; Chi W; Cao H; Cui W; Meng W
    Epigenetics Chromatin; 2019 Jun; 12(1):35. PubMed ID: 31196171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulation of p53-MDM2 auto-regulatory pathway in breast carcinoma.
    Baliou E; Nonni A; Keramopoulos D; Ragos V; Tsiambas E; Patsouris E; Pavlakis K
    J BUON; 2016; 21(5):1099-1103. PubMed ID: 27837610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma.
    Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
    Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
    Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
    Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible implication of Mdm2 as a prognostic marker in invasive laryngeal carcinoma.
    Hassumi-Fukasawa MK; Miranda-Camargo FA; Guimarães MC; Simões RT; Donadi EA; Soares CP; Soares EG
    Eur Arch Otorhinolaryngol; 2012 Jul; 269(7):1795-804. PubMed ID: 22310835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of K-Ras Over-expression in Laryngeal Squamous Cell Carcinoma.
    Papanikolaou V; Chrysovergis A; Mastronikolis S; Tsiambas E; Ragos V; Peschos D; Spyropoulou D; Pantos P; Niotis A; Mastronikolis N; Kyrodimos E
    In Vivo; 2021; 35(3):1611-1615. PubMed ID: 33910843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 and MDM2 expression in oral squamous cell carcinoma.
    Matsumura T; Yoshihama Y; Kimura T; Shintani S; Alcalde RE
    Oncology; 1996; 53(4):308-12. PubMed ID: 8692535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
    Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
    Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
    Swaroop M; Sun Y
    Anticancer Res; 2003; 23(4):3167-74. PubMed ID: 12926050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Nucleolar RNA Host Gene 12 (SNHG12) Promotes Proliferation and Invasion of Laryngeal Cancer Cells via Sponging miR-129-5p and Potentiating WW Domain-Containing E3 Ubiquitin Protein Ligase 1 (WWP1) Expression.
    Li J; Sun S; Chen W; Yuan K
    Med Sci Monit; 2019 Jul; 25():5552-5560. PubMed ID: 31348766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-4497 functions as a tumor suppressor in laryngeal squamous cell carcinoma via negatively modulation the GBX2.
    Chen X; Zhang L; Tang S
    Auris Nasus Larynx; 2019 Feb; 46(1):106-113. PubMed ID: 29843929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutations in oral cavity carcinoma.
    Ragos V; S Mastronikolis N; Tsiambas E; Baliou E; N Mastronikolis S; Tsoukalas N; E Patsouri E; P Fotiades P
    J BUON; 2018; 23(6):1569-1572. PubMed ID: 30610778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck.
    Vlatković N; El-Fert A; Devling T; Ray-Sinha A; Gore DM; Rubbi CP; Dodson A; Jones AS; Helliwell TR; Jones TM; Boyd MT
    Cancer; 2011 Jul; 117(13):2939-50. PubMed ID: 21692053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mdm2 and MdmX RING Domains Play Distinct Roles in the Regulation of p53 Responses: A Comparative Study of Mdm2 and MdmX RING Domains in U2OS Cells.
    Egorova O; Lau HH; McGraphery K; Sheng Y
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.